Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07505797 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

ATUSA Ultrasound Diagnostic Imaging for Breast Lesions Evaluation (AUDIBLE) - iSono Health

Study acronym: AUDIBLE
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 8 months later Nov 15, 2026 → Aug 2027
See other at-risk trials from iSono Health, Inc.

Record History

See every version on ClinicalTrials.gov ↗

  1. Notable Primary completion pushed from Nov 15, 2026 to Aug 2027 Show 5 more changesShow less
    • Study completion pushed from Dec 31, 2026 to Aug 2027
    • Study sites: 1 to 2
    • Eligibility criteria expanded, about 13 words
    • Secondary endpoints: details revised at 2 of 3 entries
    • Study title expanded, about 3 words
  2. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
AUDIBLE is a multi-site, clinical study conducted in the United States aimed at gathering data on 3D Automated Breast Ultrasound imaging using the iSono Health ATUSA system. The study focuses on female participants who have previously been identified with suspicious findings (classified as BIRADs 4 or 5) through standard-of-care diagnostic imaging methods (e.g., hand-held ultrasound, mammograms) and who have been referred for a biopsy. The goal is to create a comprehensive registry that includes multi-modality breast images alongside and biopsy results. The study will enroll up to 800 eligible female patients. In addition to imaging data, the study will collect information from the patient's medical records and biopsy outcomes. The study aims to validate ATUSA's image quality, reproducibility, and correlation with histopathology and radiologist-assigned BI-RADS categories. Additionally, a subset of participants receiving neoadjuvant therapy will be followed longitudinally to evaluate ATUSA's potential for monitoring treatment response and volumetric changes in tumor burden. This study supports the advancement of a patient-friendly, radiation-free, operator-independent ultrasound platform for real-time breast imaging.
Trial Details
NCT Number NCT07505797
Lead Sponsor iSono Health, Inc.
Collaborators: National Cancer Institute (NCI)
Conditions
(from sponsor)
Breast Cancer, Benign Breast Condition, Breast Fibroadenoma, Breast Neoplasms, Breast Disease, Breast Cancer Female, Breast Pain, Breast Cancer Invasive +1 more
Related terms Breast Diseases, Breast Neoplasms, Cystic Fibrosis, Fibroadenoma, Mastodynia
Enrollment 800 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov